Another year has passed and a handful of notable media misreports along with it. One of the most prestigious journalists was caught plagiarizing another journalist’s work this year as
Credit:http://www.sonofthesouth.net
2012 was a powerful whirlwind in foreign policy. Some of the major foreign policy events of 2012 will continue to shape geopolitical relations around the
The White House Christmas tree was lit by President Obama earlier this month, alongside his family and several thousands spectators. Although there are several Christmas trees throughout the White House,
credit: http://ubcmisa.org
From fights for equality in schooling overseas to new approaches to the issues that affect our campuses, education in 2012 had its share of highlights and
2012 was an exciting year for the Securities and Exchange Commission. This year the UK emerged as a hotbed for corrupt bankers following the Libor interest-rate fixing scandal. Goldman
Congressman Bob Goodlatte
An update to the Video Privacy Protection Act, instated in 1988, will allow Netflix subscribers in the U.S. to automatically share account activity on social networking
Over the course of the year, social media experienced its fair share of "firsts." Marked by major events like the Summer Olympics, the presidential election, Hurricane Sandy, and
The Year 2012 in ReviewWith 2012 coming to an end, time has come to evaluate the year we just lived. On the surface, not much changed in 2012 with respect
The Year 2012 in ReviewWith 2012 coming to an end, time has come to evaluate the year we just lived. On the surface, not much changed in 2012 with respect
2012 was a big year for IVN. It was a year of significant expansion and accomplishments. IVN reached out to an audience of over seven million people with content written
For many people, the end of the year is marked by the celebration of whatever holiday one chooses to acknowledge during the holiday season and the welcoming of a new
Photo: Harvard University Drug and Alcohol Peer Advisors
The National Institute of Health is working with an experimental antidepressant called AZD6765, using the properties of ketamine as a model.
Clinical